Sustained release nitric oxide from long-lived circulating nanoparticles

Free Radical Biology and Medicine

Volumn 49, Issue 4, 2010, Pages 530-538

  Cabrales, Pedro ^a   Han, George ^b   Roche, Camille ^b   Nacharaju, Parimala ^b   Friedman, Adam J ^b   Friedman, Joel M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular; Hypertension; Intravascular gas delivery; Nanotechnology; Vasodilation

Indexed keywords

GLASS; NANOPARTICLE; NITRIC OXIDE; NITRITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; HYDRATION; HYDROGEL; INFLAMMATION; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; VASODILATATION;

ANIMALS; CRICETINAE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HYDROGEL; HYDROGEN-ION CONCENTRATION; MALE; NANOPARTICLES; NANOTECHNOLOGY; NITRIC OXIDE; PARTICLE SIZE; SIGNAL TRANSDUCTION;

EID: 77954542992     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.04.034     Document Type: Article

References (29)

1. Zacharia I.G., Deen W.M. Diffusivity and solubility of nitric oxide in water and saline. Ann. Biomed. Eng. 2005, 33:214-222.
2. Moncada S., Palmer M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-134.
3. Busse R., Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J. Vasc. Res. 1998, 35:73-84.
4. Lancaster J.R. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1997, 1:18-30.
5. Ichinose F., Roberts J.D., Zapol W.M. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation 2004, 109:3106-3111.
6. Zapol W.M. Inhaled nitric oxide. Acta Anaesthesiol. Scand. Suppl. 1996, 109:81-83.
7. Homer K., Wanstall J. In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries. Eur. J. Pharmacol. 1998, 356:49-57.
8. Friedman A.J., Han G., Navati M.S., Chacko M., Gunther L., Alfieri A., Friedman J.M. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008, 19:12-20.
9. Maragos C.M., Morley D., Wink D.A., Dunams T.M., Saavedra J.E., Hoffman A., Bove A.A., Isaac L., Hrabie J.A., Keefer L.K. Complexes of. NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 1991, 34:3242-3247.
10. Maragos C.M., Wang J.M., Hrabie J.A., Oppenheim J.J., Keefer L.K. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res. 1993, 53:564-568.
11. Homer K.L., Wanstall J.C. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor. Br. J. Pharmacol. 2000, 131:673-682.
12. Endrich B., Asaishi K., Götz A., Messmer K. Technical report: a new chamber technique for microvascular studies in unanaesthetized hamsters. Res. Exp. Med. 1980, 177:125-134.
13. Sakata M., Yoshida A., Haga M. Methemoglobin in blood as determined by double-wavelength spectrophotometry. Clin. Chem. 1982, 28:508-511.
14. Childs E.W., Udobi K.F., Wood J.G., Hunter F.A., Smalley D.M., Cheung L.Y. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. Shock 2002, 18:423-427.
15. Tapec R., Zhao X.J., Tan W. Development of organic dye-doped silica nanoparticles for bioanalysis and biosensors. J. Nanosci. Nanotechnol. 2002, 2:405-409.
16. Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 1996, 50:1-5.
17. Rybalkin S.D., Yan C., Bornfeldt K.E., Beavo J.A. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ. Res. 2003, 93:280-291.
18. Allman K.G., Young J.D., Carapiet D., Stevens J.E., Ostman-Smith I., Archer L.N. Effects of oxygen and nitric oxide in oxygen on pulmonary arterial pressures of children with congenital cardiac defects. Pediatr. Cardiol. 1996, 17:246-250.
19. Wanstall J.C., Kaye J.A., Gambino A. The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats. Br. J. Pharmacol. 1997, 121:280-286.
20. Ray A., Friedman B.A., Friedman J.M. Trehalose glass-facilitated thermal reduction of metmyoglobin and methemoglobin. J. Am. Chem. Soc. 2002, 124:7270-7271.
21. Navati M.S., Friedman J.M. Sugar-derived glasses support thermal and photo-initiated electron transfer processes over macroscopic distances. J. Biol. Chem. 2006, 281:36021-36028.
22. Navati M.S., Friedman J.M. Glass matrix-facilitated thermal reduction: a tool for probing reactions of met hemoglobin with nitrite and nitric oxide. J. Phys. Chem. B 2010, 114:2938-2943.
23. Navati M.S., Friedman J.M. Reactivity of glass-embedded met hemoglobin derivatives toward external NO: implications for nitrite-mediated production of bioactive NO. J. Am. Chem. Soc. 2009, 131:12273-12279.
24. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one. Mol. Pharmacol. 1995, 48:184-188.
25. Pollman M.J., Yamada T., Horiuchi M., Gibbons G.H. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ. Res. 1996, 79:748-756.
26. Moghimi S.M., Gray T. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats. Clin. Sci. (Lond.) 1997, 93:371-379.
27. Rutherford M.S., Witsell A., Schook L.B. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J. Leukoc. Biol. 1993, 53:602-618.
28. Ito S., Naito M., Kobayashi Y., Takatsuka H., Jiang S., Usuda H., Umezu H., Hasegawa G., Arakawa M., Shultz L.D., Elomaa O., Tryggvason K. Roles of a macrophage receptor with collagenous structure (MARCO) in host defense and heterogeneity of splenic marginal zone macrophages. Arch. Histol. Cytol. 1999, 62:83-95.
29. Martinez L.R., Han G., Chacko M., Mihu M.R., Jacobson M., Gialanella P., Friedman A.J., Nosanchuk J.D., Friedman J.M. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against staphylococcus aureus skin infection. J. Invest. Dermatol. 2009, 129:2463-2469.